[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Alpha- Antitrypsin Deficiency Treatment Market Report 2018

January 2018 | 112 pages | ID: U2BD1E3C4C1EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Alpha- Antitrypsin Deficiency Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Alpha- Antitrypsin Deficiency Treatment in these regions, from 2013 to 2025 (forecast).
United States Alpha- Antitrypsin Deficiency Treatment market competition by top manufacturers/players, with Alpha- Antitrypsin Deficiency Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Adverum Biotechnologies, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Applied Genetic Technologies Corporation
  • Arrowhead Pharmaceuticals, Inc.
  • Carolus Therapeutics, Inc.
  • Cevec Pharmaceuticals GmbH
  • Dicerna Pharmaceuticals, Inc.
  • Digna Biotech, S.L.
  • Editas Medicine, Inc.
  • Grifols, S.A.
  • Inhibrx
  • Intellia Therapeutics, Inc.
  • International Stem Cell Corporation
  • Ionis Pharmaceuticals, Inc.
  • Kamada Ltd.
  • Polyphor Ltd.
  • ProMetic Life Sciences Inc.
  • rEVO Biologics, Inc.
  • Sangamo BioSciences, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • CT-2009
  • POL-6014
  • ARO-AAT
  • ALNAAT-02
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Alpha- Antitrypsin Deficiency Treatment Market Report 2018

1 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT OVERVIEW

1.1 Product Overview and Scope of Alpha- Antitrypsin Deficiency Treatment
1.2 Classification of Alpha- Antitrypsin Deficiency Treatment by Product Category
  1.2.1 United States Alpha- Antitrypsin Deficiency Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Alpha- Antitrypsin Deficiency Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 CT-2009
  1.2.4 POL-6014
  1.2.5 ARO-AAT
  1.2.6 ALNAAT-02
  1.2.7 Others
1.3 United States Alpha- Antitrypsin Deficiency Treatment Market by Application/End Users
  1.3.1 United States Alpha- Antitrypsin Deficiency Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Alpha- Antitrypsin Deficiency Treatment Market by Region
  1.4.1 United States Alpha- Antitrypsin Deficiency Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
  1.4.3 Southwest Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
  1.4.5 New England Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
  1.4.6 The South Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
  1.4.7 The Midwest Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Alpha- Antitrypsin Deficiency Treatment (2013-2025)
  1.5.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2025)
  1.5.2 United States Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2025)

2 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Alpha- Antitrypsin Deficiency Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Alpha- Antitrypsin Deficiency Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Alpha- Antitrypsin Deficiency Treatment Market Competitive Situation and Trends
  2.4.1 United States Alpha- Antitrypsin Deficiency Treatment Market Concentration Rate
  2.4.2 United States Alpha- Antitrypsin Deficiency Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alpha- Antitrypsin Deficiency Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Alpha- Antitrypsin Deficiency Treatment Price by Region (2013-2018)

4 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Alpha- Antitrypsin Deficiency Treatment Price by Type (2013-2018)
4.4 United States Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Adverum Biotechnologies, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Alnylam Pharmaceuticals, Inc.
  6.2.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Applied Genetic Technologies Corporation
  6.3.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Arrowhead Pharmaceuticals, Inc.
  6.4.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Carolus Therapeutics, Inc.
  6.5.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Cevec Pharmaceuticals GmbH
  6.6.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Dicerna Pharmaceuticals, Inc.
  6.7.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Digna Biotech, S.L.
  6.8.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Editas Medicine, Inc.
  6.9.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Grifols, S.A.
  6.10.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Inhibrx
6.12 Intellia Therapeutics, Inc.
6.13 International Stem Cell Corporation
6.14 Ionis Pharmaceuticals, Inc.
6.15 Kamada Ltd.
6.16 Polyphor Ltd.
6.17 ProMetic Life Sciences Inc.
6.18 rEVO Biologics, Inc.
6.19 Sangamo BioSciences, Inc.

7 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MANUFACTURING COST ANALYSIS

7.1 Alpha- Antitrypsin Deficiency Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Alpha- Antitrypsin Deficiency Treatment
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Size (K Pcs) by Type (2013-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure CT-2009 Product Picture
Figure POL-6014 Product Picture
Figure ARO-AAT Product Picture
Figure ALNAAT-02 Product Picture
Figure Others Product Picture
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
Figure 2017 United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players/Suppliers
Table United States Market Alpha- Antitrypsin Deficiency Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Alpha- Antitrypsin Deficiency Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Share of Top 3 Players/Suppliers
Figure United States Alpha- Antitrypsin Deficiency Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alpha- Antitrypsin Deficiency Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alpha- Antitrypsin Deficiency Treatment Product Category
Table United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) by Region (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Region (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Region (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region in 2017
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Region (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region in 2017
Table United States Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) by Region (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) by Type (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type in 2017
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Type in 2017
Table United States Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) by Types (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Type (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) by Application (2013-2018)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application in 2017
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Application (2013-2018)
Table Adverum Biotechnologies, Inc. Basic Information List
Table Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Alnylam Pharmaceuticals, Inc. Basic Information List
Table Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Applied Genetic Technologies Corporation Basic Information List
Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Arrowhead Pharmaceuticals, Inc. Basic Information List
Table Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Carolus Therapeutics, Inc. Basic Information List
Table Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Cevec Pharmaceuticals GmbH Basic Information List
Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Dicerna Pharmaceuticals, Inc. Basic Information List
Table Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Digna Biotech, S.L. Basic Information List
Table Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Editas Medicine, Inc. Basic Information List
Table Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Grifols, S.A. Basic Information List
Table Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in United States (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in United States (2013-2018)
Table Inhibrx Basic Information List
Table Intellia Therapeutics, Inc. Basic Information List
Table International Stem Cell Corporation Basic Information List
Table Ionis Pharmaceuticals, Inc. Basic Information List
Table Kamada Ltd. Basic Information List
Table Polyphor Ltd. Basic Information List
Table ProMetic Life Sciences Inc. Basic Information List
Table rEVO Biologics, Inc. Basic Information List
Table Sangamo BioSciences, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Figure Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
Figure Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
Table Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Players/Suppliers in 2017
Table Major Buyers of Alpha- Antitrypsin Deficiency Treatment
Table Distributors/Traders List
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories